| Literature DB >> 27486355 |
Harold I Zeliger1, Boguslaw Lipinski2.
Abstract
The onset of human degenerative diseases in humans, including type 2 diabetes, cardiovascular disease, neurological disorders, neurodevelopmental disease and neurodegenerative disease has been shown to be related to exposures to persistent organic pollutants, including polychlorinated biphenyls, chlorinated pesticides, polybrominated diphenyl ethers and others, as well as to polynuclear aromatic hydrocarbons, phthalates, bisphenol-A and other aromatic lipophilic species. The onset of these diseases has also been related to exposures to transition metal ions. A physiochemical mechanism for the onset of degenerative environmental disease dependent upon exposure to a combination of lipophilic aromatic hydrocarbons and transition metal ions is proposed here. The findings reported here also, for the first time, explain why aromatic hydrocarbons exhibit greater toxicity than aliphatic hydrocarbons of equal carbon numbers.Entities:
Keywords: Alzheimer's disease; cancer; degenerative environmental disease; diabetes; membrane permeability; toxicity mechanism
Year: 2015 PMID: 27486355 PMCID: PMC4961921 DOI: 10.1515/intox-2015-0003
Source DB: PubMed Journal: Interdiscip Toxicol ISSN: 1337-6853
Figure 1Polymerization of human fibrinogen (optical density), and hydroxyl radical generation (fl uorescence intensity) as a function of iron (ferric chloride) concentration.
Blood:air partition coefficient (PC) and permissible exposure level (PEL) data (given in parts per million) for C6-C8 hydrocarbons.
| Carbon number | Compound | PC | PEL |
|---|---|---|---|
| 6 | benzene | 7.8 | 1 |
| Cyclohexane | 1.3 | 300 | |
| 7 | toluene | 15.6 | 300 |
| n-heptane | 1.9 | 500 | |
| 8 | p-xylene | 28.4 | 100 |
| n-octane | 3.1 | 500 |
The aromatic compound is listed first in each carbon number pair.
PEL values are those used by OSHA (OSHA, 2014).
Environmental chemical-induced diseases and their causative chemicals.
| CHEMICALS | |||||||
|---|---|---|---|---|---|---|---|
| DISEASES | POPs | PTL | BPA | PAH | TRM | SRA | |
| T2D | 1 | 1 | 1 | 1 | 1,3–5 | 1 | |
| CVD | 6 | 6 | 6 | 6 | 7 | 1 | |
| NRD | 8 | 8 | 8 | 8 | 7–12 | 8 | |
| IMM | 1 | 6 | 6 | 6 | 7,13 | 6 | |
| CAN | 1 | 14 | 14 | 15 | 7,18 | 16 | |
| OBS | 1 | 1 | 1 | 1,17 | 9 | 1 | |
| END | 1 | 1 | 1 | 2,17 | 2 | 17 | |
Abbreviations: T2D - type 2 diabetes; CVD - cardiovascular disease; NRD - neurological diseases, including neurological impairments, neurodevelopmental disorders and neurodegenerative diseases; IMM - immunological disease; CAN - cancer; OBS - obesity; END - endocrine disruption; POPs - persistent organic pollutants (including dioxins and furans, PCBs, OCs and PBDEs); PTL - phthalates; BPA - bisphenol A; PAH - polynuclear aromatic hydrocarbons; SRA - single ring aromatic compounds; TRM - transition metals (including silver, copper, vanadium, zinc, cobalt, mercury, lead, cadmium, arsenic, manganese and chromium). References are as follows: 1 - Zeliger, 2013; 2 - Rana, 2014; 3 - Chen et al., 2009; 4 - Kuo, et al 2013; 5 - Xu et al., 2013; 6 - Zeliger, 2013a; 7-Jarup 2003; 8 - Zeliger, 2013b; 9 - Rossignol et al., 2014; 10 - Kumundi et al., 2014; 11 - Fukushima et al., 2014; 12 - Lipinski & Pretorius, 2013a; Bai et al., 2014; 14 - Sprague et al., 2013; 15 - Bostrom et al., 2002; 16 - Vizcaya et al., 2014; 17 - Scinicariello et al., 2014; 18 - Mates et al., 2010; 19 - Padilla et al., 2010.